arrow
D

Dace Zavadska

children clinical university hospital
H指数:24
被引数:2,052

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Factors associated with SARS-CoV-2 infection among healthcare workers: a European multicentre cohort study, May 2021–April 2024

与医疗保健工作者SARS-CoV-2感染相关的因素:一项欧洲多中心队列研究,2021年5月至2024年4月

2026-08-070
OA
Vaccination policies for healthcare personnel in Europe, 2026

欧洲医疗保健人员疫苗接种政策,2026

Vaccine
IF3.5
2026-07-010
PRE
Immunogenicity and safety of an investigational quadrivalent measles, mumps, rubella, and varicella vaccine in children aged 4–6 years: A phase II, randomized, multi-country trial

4~6岁儿童四价麻疹、腮腺炎、风疹和带状疱疹疫苗的免疫原性和安全性:一项II期、随机、多国家试验

2026-05-260
OA
Predicting trajectories of illness using RNA velocity of whole blood

利用全血RNA速度预测疾病轨迹

2026-05-060
OAAI
Effectiveness, immunogenicity and safety of human papillomavirus vaccination in non-HIV immunocompromised individuals: a systematic review

人乳头瘤病毒疫苗接种在非HIV免疫受损个体中的有效性、免疫原性和安全性:一项系统评价

2026-04-110
OAAI
The Ongoing Challenge of Pertussis in Eastern and Northern Europe: Recommendations from the Global Pertussis Initiative

东欧和北欧百日咳持续存在的挑战:全球百日咳倡议的建议

2026-04-020
OAAI
Genome-wide association study identifies ABCG1 as a susceptibility locus for tick-borne encephalitis

全基因组关联研究将ABCG1鉴定为蜱传脑炎的易感位点。

2025-11-120
OAAI
Paediatric invasive group A streptococcal infections and associations with viral infections in 15 European countries after lifting non-pharmaceutical interventions against SARS-CoV-2: an interrupted time-series analysis

15个欧洲国家在取消针对SARS-CoV-2的非药物干预措施后,儿科侵袭性A族链球菌感染及其与病毒感染的关联:一项中断时间序列分析

2025-10-180
OAAI
Tick-borne encephalitis vaccine effectiveness and public health impact in the Baltic countries of Estonia, Latvia, and Lithuania, 2019-2023

蜱传脑炎疫苗有效性及在波罗的海国家(爱沙尼亚、拉脱维亚和立陶宛)的公共卫生影响,2019-2023

2025-09-010
OAAI
A 5-transcript signature for discriminating viral and bacterial etiology in pediatric pneumonia

一种5转录本特征,用于区分儿童肺炎的病毒性和细菌性病因

2025-02-011
OAAI
Evaluating the need for standardised disease manifestation categories in patients infected with the tick-borne encephalitis virus: A Delphi panel
2025-01-010
OAAI
Relative effectiveness of the second booster COVID-19 vaccines against laboratory confirmed SARS-CoV-2 infection in healthcare workers: VEBIS HCW VE cohort study (1 October 2022-2 May 2023)

第二剂加强针COVID-19疫苗在预防实验室确诊SARS-CoV-2感染方面的相对有效性:医疗保健工作者VEBIS HCW VE队列研究(2022年10月1日至2023年5月2日)

VACCINE
IF3.5
2025-01-010
OAAI
Incidence of SARS-CoV-2 Infection Among European Healthcare Workers and Effectiveness of the First Booster COVID-19 Vaccine, VEBIS HCW Observational Cohort Study, May 2021-May 2023

欧洲卫生保健工作者中SARS-CoV-2感染的发生率和第一个加强新型冠状病毒肺炎疫苗的有效性,VEBIS HCW观察性队列研究,2021年5月-2023年5月

2024-11-192
OAAI
Effectiveness of the autumn 2023 COVID-19 vaccine dose in hospital-based healthcare workers: results of the VEBIS healthcare worker vaccine effectiveness cohort study, seven European countries, season 2023/24
2024-10-310
OAAI